Capricor Therapeutics, Inc. (CAPR) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CAPRCapricor Therapeutics, Inc.Follow CAPR — free
—
Price chart with a free account
- Market cap
- 344.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -361.7% | -1074.2% | -1371.7% | -125.7% | -228.6% | -424.6% | -482.4% | -917.0% | -769.5% | -4412.6% | -8549.9% | -1163.9% | -95.6% | -191.1% | — | — | |
| Net margin | -84.9% | -1059.5% | -1767.0% | -129.9% | -233.0% | -470.3% | 91.2% | -908.9% | -760.4% | -4401.9% | -8175.9% | -1137.4% | -88.5% | -181.7% | — | — | |
| FCF margin | -343.4% | -1125.4% | -1232.1% | 16.6% | -198.4% | -366.3% | -534.9% | -848.3% | -678.7% | -3417.4% | -7352.3% | 61.0% | -109.8% | -186.5% | — | — |
USD millions · SEC XBRL
Every figure on this page comes from Capricor Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.